| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/17425255.2012.701618 |
| P698 | PubMed publication ID | 22762358 |
| P50 | author | Paolo Martelletti | Q42333835 |
| P2093 | author name string | Maurizio Simmaco | |
| Luana Lionetto | |||
| Barbara Casolla | |||
| Andrea Negro | |||
| Fabiola Mastropietri | |||
| Lidia D'Alonzo | |||
| P2860 | cites work | Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group | Q39425621 |
| The Mode of Action of Sumatriptan is Vascular? A Debate | Q40494636 | ||
| Transmural myocardial infarction with sumatriptan | Q42284414 | ||
| Demographic and migraine characteristics of adolescents with migraine: Glaxo Wellcome clinical trials' database | Q42599388 | ||
| Zolmitriptan versus sumatriptan comparison trial | Q43551366 | ||
| The pharmacokinetics of the antimigraine compound zolmitriptan in Japanese and Caucasian subjects | Q44075843 | ||
| Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet | Q44492681 | ||
| Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study | Q44751658 | ||
| Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine | Q44776561 | ||
| Zolmitriptan nasal spray exhibits good long-term safety and tolerability in migraine: results of the INDEX trial | Q45233114 | ||
| Myocardial infarction after oral sumatriptan use in a woman with normal coronary arteries | Q46919657 | ||
| fMRI identifies regional specialization of neural networks for reading in young children | Q48410636 | ||
| Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat. | Q48715691 | ||
| Pharmacokinetics and pharmacodynamics of zolmitriptan in patients with mild to moderate hypertension: a double-blind, placebo-controlled study. | Q50868159 | ||
| Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches. | Q54031372 | ||
| Genetics of migraine in the age of genome-wide association studies | Q24613478 | ||
| Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society | Q24633523 | ||
| Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system | Q24646305 | ||
| Vasoactive peptide release in the extracerebral circulation of humans during migraine headache | Q28265001 | ||
| Mechanisms of action of the 5-HT1B/1D receptor agonists | Q33960161 | ||
| Triptans for the management of migraine | Q34129854 | ||
| The triptan formulations: a critical evaluation | Q34205890 | ||
| Almotriptan and zolmitriptan in the acute treatment of migraine | Q34573136 | ||
| Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials | Q34647375 | ||
| Efficacy of zolmitriptan nasal spray in adolescent migraine | Q34654606 | ||
| Serotonin and migraine: biology and clinical implications | Q34655338 | ||
| The pharmacokinetics and effects on blood pressure of multiple doses of the novel anti-migraine drug zolmitriptan (311C90) in healthy volunteers | Q34738942 | ||
| The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90). | Q34741307 | ||
| Why pharmacokinetic differences among oral triptans have little clinical importance: a comment | Q34770884 | ||
| Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan). | Q35026033 | ||
| Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans | Q35091964 | ||
| The triptan formulations : how to match patients and products | Q35107741 | ||
| Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine | Q35234469 | ||
| Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine | Q35775292 | ||
| The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers | Q35802614 | ||
| Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy | Q36367884 | ||
| Prevalence of headache and migraine in schoolchildren | Q36887035 | ||
| Clinical pharmacology of the serotonin receptor agonist, zolmitriptan | Q37008907 | ||
| Acute and preventive pharmacologic treatment of cluster headache | Q37777291 | ||
| Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. | Q39325330 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | migraine | Q133823 |
| pharmacokinetics | Q323936 | ||
| P304 | page(s) | 1043-1050 | |
| P577 | publication date | 2012-07-05 | |
| P1433 | published in | Expert Opinion on Drug Metabolism & Toxicology | Q5421205 |
| P1476 | title | Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines | |
| P478 | volume | 8 |
| Q38866983 | Acute, transitional and long-term cluster headache treatment: pharmacokinetic issues |
| Q47968905 | Cluster headache management and beyond |
| Q38378898 | Drug safety in acute migraine treatment. |
| Q33671813 | Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans |
| Q30831647 | Network meta-analysis of migraine disorder treatment by NSAIDs and triptans |
| Q88716799 | Pharmacokinetics and Skin Tolerability of Intracutaneous Zolmitriptan Delivery in Swine Using Adhesive Dermally Applied Microarray |
| Q38674724 | Population Pharmacokinetic Analysis of Zolmitriptan and Its Metabolite in Adults and Adolescents to Support Dose Selection in Children With Migraine. |
| Q47883597 | Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarray |
| Q48715159 | The therapeutic potential of novel anti-migraine acute therapies |
| Q36749560 | Triptans in prevention of menstrual migraine: a systematic review with meta-analysis |
Search more.